What Is the Best Treatment for Chronic Insomnia?
Reviewed by our editorial team
Last updated: 2026-04-01
Quick Answer
Cognitive Behavioral Therapy for Insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia, with superior long-term outcomes compared to sleep medications and no risk of dependence.
Chronic insomnia affects an estimated 10–15% of adults globally. Despite its prevalence, it remains undertreated: most people who seek help are offered sleep medications rather than the behavioral treatment that guidelines consistently rank as most effective.
The American Academy of Sleep Medicine, the American College of Physicians, and the National Institute for Health and Care Excellence all recommend CBT-I as the first-line treatment for chronic insomnia in adults. Sleep medications are recommended only when CBT-I is not available, has not worked, or as a short-term bridge while awaiting behavioral treatment.
Why CBT-I Is the Top Recommendation
CBT-I addresses the root causes of chronic insomnia — learned hyperarousal, conditioned wakefulness, unhelpful sleep beliefs, and lifestyle factors — rather than just suppressing symptoms with medication. Clinical trials show that CBT-I produces sleep improvements that continue to grow in the months after treatment ends, while the effects of sleep medications typically diminish when the medication is stopped.
Meta-analyses show that CBT-I reduces time to fall asleep by an average of 19 minutes, reduces nighttime waking by 26 minutes, and improves sleep efficiency significantly. These effects are comparable to or better than those of sleep medications in the short term — and substantially better in the long term. Critically, CBT-I carries no risk of dependence, tolerance, or next-morning sedation.
When Sleep Medications Are Used
Sleep medications are appropriate for specific circumstances: as short-term treatment for acute insomnia, as a bridge during the early weeks of CBT-I, or for patients who are unable to engage with behavioral treatment due to cognitive or practical limitations.
FDA-approved sleep medications for insomnia include non-benzodiazepine receptor agonists (Z-drugs: zolpidem, eszopiclone, zaleplon), melatonin receptor agonists (ramelteon), dual orexin receptor antagonists (suvorexant, lemborexant), and the histamine antagonist doxepin at low doses. Benzodiazepines are generally not recommended for chronic insomnia due to tolerance, dependence, and fall risk.
Complementary Approaches
Sleep hygiene improvements — consistent sleep timing, appropriate bedroom environment, caffeine management — are part of standard CBT-I but are not sufficient alone for chronic insomnia. Mindfulness-based therapy for insomnia (MBTI) combines mindfulness meditation with CBT-I elements and has demonstrated effectiveness, particularly for people with anxiety or difficulty disengaging from rumination.
Digital CBT-I programs (Sleepio, Somryst) have been validated in randomized trials and provide accessible, effective CBT-I delivery for people without access to in-person therapy. Exercise — particularly moderate aerobic exercise — consistently improves sleep quality as an adjunct treatment. Reducing alcohol consumption is also important: alcohol disrupts sleep architecture in the second half of the night.
Frequently Asked Questions
References
- [1]American College of Physicians. Management of Chronic Insomnia Disorder in Adults. Ann Intern Med. 2016.
- [2]American Academy of Sleep Medicine. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults. 2017.
The information on this page is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.